Group 1 - The core point of the news is that Lingkang Pharmaceutical experienced a slight decline in stock price on August 13, closing at 6.04 yuan, down 0.01 yuan or 0.17% from the previous trading day [1] - The company operates in the chemical pharmaceutical industry, focusing on pharmaceutical manufacturing and distribution, with a product line that includes anti-infection drugs and digestive system medications [1] - Lingkang Pharmaceutical has a total market capitalization of 4.356 billion yuan, with the circulating market value equal to the total market value [1] Group 2 - On August 13, Lingkang Pharmaceutical saw a rapid rebound in the morning session, with price fluctuations exceeding 2% within five minutes, and a transaction amount of 40.9827 million yuan, indicating a certain level of market activity [1] - In terms of capital flow, on August 13, the net outflow of main funds for Lingkang Pharmaceutical was 24.5548 million yuan, with a cumulative net outflow of 6.1632 million yuan over the past five trading days [2]
灵康药业股价微跌0.17% 化学制药企业成交额突破2亿元